Kit & Assay Notices

Access Array Target Specific Primers and Reagents Patent Notice June 11, 2014

Access Array Target Specific Primers and Reagents

Fluidigm Product Patent Notice

This product and its use with the Access Array System may be covered U.S. Patent 8,691,509, owned by Fluidigm Corporation, and additional foreign patents and pending patent applications.

For Research Use Only.  Not for use in diagnostic procedures.

Fluidigm Reverse Transcription Master Mix Patent Notice June 11, 2014

Fluidigm Reverse Transcription Master Mix

Fluidigm Product Patent Notice

The use of Fluidigm Reverse Transcription Master Mix together with Fluidigm products including IFCs (integrated fluidic circuits/microfluidic chips with or without a carrier) such as C1 Single-Cell Auto Prep Array IFCs, Access Array IFCs, Dynamic Array IFCs and Digital Array IFCs, the IFC controller, FC1 Cycler and the Fluidigm system (C1 Single-Cell Auto Prep System, Biomark HD System, EP1 System, readers, thermal cycler, etc.) and methods for reading and controlling the C1 Single-Cell Auto Prep Array IFCs, Access Array IFCs, Dynamic Array IFCs and Digital Array IFCs and/or their use and manufacture may be covered by one or more of the following patents owned by Fluidigm Corporation and/or sold under license from California Institute of Technology and other entities: : U.S. Patent Nos. 6,408,878, 6,645,432, 6,719,868, 6,793,753, 6,929,030, 7,195,670, 7,216,671, 7,307,802, 7,323,143, 7,476,363, 7,479,186, 7,494,555, 7,588,672, 7,601,270, 7,604,965, 7,666,361, 7,691,333, 7,704,735, 7,749,737, 7,766,055, 7,815,868, 7,837,946, 7,867,454, 7,867,763, 7,906,072, 8,048,378, 8,104,497, 8,104,515, 8,105,553, 8,105,824, 8,129,176, 8,157,434, 8,163,492, 8,273,574, 8,257,666, 8,389,960, 8,512,640, 8,616,227, 8,721,968; and additional issued and pending patents in the U.S. and other countries.

Fluidigm, the Fluidigm logo, Access Array, Biomark, C1, Dynamic Array, Digital Array, EP1, and FC1, are trademarks or registered trademarks of Fluidigm Corporation in the U.S. and/or other countries.

© Fluidigm Corporation. All rights reserved.

For Research Use Only. Not for use in diagnostic procedures.

Maxpar and Cell-ID Reagents Patent Notice and Limited License February 24, 2020

Maxpar® Metal Conjugated Antibodies, Maxpar® Panel Kits, Maxpar® Metal Labeling Kits, and Cell-ID™ Cell Labeling Reagents (Collectively Maxpar and Cell-ID reagents)

Fluidigm Product Patent Notice

The Maxpar and Cell-ID reagents and their use with the CyTOF®, CyTOF® 2, Helios™, and Hyperion™ Imaging Systems may be covered by one or more of the following U.S. Patents owned or licensed by Fluidigm Corporation and/or its affiliates: 7,135,296, 7,479,630, 7,700,295, 7,767,407, 8,003,312, 8,101,368, 8,236,511, 8,354,242, 9,012239, 9,176,137, 9,296,838, 9,739,765, 10,072,104, 10,180,386, 10,436,698 and additional foreign patents and pending patent applications. Fluidigm, the Fluidigm logo, Cell-ID, CyTOF, Helios, Hyperion, and Maxpar are trademarks and/or registered trademarks of Fluidigm Corporation in the U.S. and/or other countries.

Fluidigm, the Fluidigm logo, Cell-ID, CyTOF, Helios, Hyperion, and Maxpar are trademarks and/or registered trademarks of Fluidigm Corporation in the U.S. and/or other countries

For Research Use Only. Not for use in diagnostic procedures.

Note to Purchaser: Limited License

The purchase of Maxpar and Cell-ID reagents conveys from Fluidigm to the purchaser a limited, non-transferable right to use the reagents only with Fluidigm instruments and systems (CyTOF®, CyTOF® 2, Helios™, and Hyperion™ Imaging Systems). For information on obtaining additional usage rights, please contact Fluidigm at www.fluidigm.com/support.

PreAmp Master Mix Patent Label and Limited License June 11, 2014

Fluidigm PreAmp Master Mix

Fluidigm Product Patent Notice and Limited License

The use of Fluidigm PreAmp Master Mix together with Fluidigm products including IFCs (integrated fluidic circuits/microfluidic chips with or without a carrier) such as C1 Single-Cell Auto Prep Array IFCs, Access Array IFCs, Dynamic Array IFCs and Digital Array IFCs, the IFC controller, FC1 Cycler and the Fluidigm system (Biomark HD System, EP1 System, readers, thermal cycler, etc.) and methods for reading and controlling the C1 Single-Cell Auto Prep Array IFCs, Access Array IFCs, Dynamic Array IFCs and Digital Array IFCs and/or their use and manufacture may be covered by one or more of the following patents owned by Fluidigm Corporation and/or sold under license from California Institute of Technology and other entities: U.S. Patent Nos. 6,408,878, 6,645,432, 6,719,868, 6,793,753, 6,929,030, 7,195,670, 7,216,671, 7,307,802, 7,323,143, 7,476,363, 7,479,186, 7,494,555, 7,588,672, 7,601,270, 7,604,965, 7,666,361, 7,691,333, 7,704,735, 7,749,737, 7,766,055, 7,815,868, 7,837,946, 7,867,454, 7,867,763, 7,906,072, 8,048,378, 8,104,497, 8,104,515, 8,105,553, 8,105,824, 8,129,176, 8,157,434, 8,163,492, 8,273,574, 8,257,666, 8,389,960, 8,512,640, 8,616,227, 8,721,968; and additional issued and pending patents in the U.S. and other countries.

Fluidigm, the Fluidigm logo, Access Array, Biomark, C1, Dynamic Array, Digital Array, EP1, and FC1, are trademarks or registered trademarks of Fluidigm Corporation in the U.S. and/or other countries. © Fluidigm Corporation. All rights reserved.

For Research Use Only. Not for use in diagnostic procedures.

NOTICE TO PURCHASER: Limited Use License to Perform Preamplification with Fluidigm IFCs. The purchase of a C1 Single-Cell Auto Prep Array IFC , Digital Array IFC, or Dynamic Array IFC from Fluidigm Corporation conveys to the purchaser the limited, non-transferable right to perform preamplification methods under license from Life Technologies Corporation for use with the purchased amount of this product and Fluidigm instruments. No right to resell this product and no other rights (such as real-time PCR methods, apparatus, reagents or software to perform digital PCR methods) are conveyed by Life Technologies Corporation expressly, by implication, or by estoppel. For information on obtaining additional rights, please contact outlicensing@lifetech.com or Out Licensing, Life Technologies, 5791 Van Allen Way, Carlsbad, California 92008. For information about the scope of the above-identified Fields, please contact labellicenseinformation@fluidigm.com.

Unless explicitly and expressly stated otherwise, all Fluidigm products are provided for Research Use Only, not for use in diagnostic procedures. For more information see www.fluidigm.com/legal/notices